Phytosterolaemia (beta(-)sitosterolaemia), a rare, autosomal recessive
disorder, has not hitherto been reported in Southern Africa. We repor
t four new homozygous patients, from three unrelated families with sig
nificant beta-sitosterolaemia (6.6-11.3%), campesterolaemia (2.2-4.6%)
and clearly detectable, though unquantified, levels of cholestanol. T
hree of the four patients had characteristic cutaneous and tendinous x
anthomas within the first decade of life. The fourth patient, a 5 year
old, was free of xanthomas despite persistently elevated concentratio
ns of plant sterols in her plasma. Ail our patients were female bringi
ng the male:female ratio in reported cases to 8:23. All were at or bel
ow the 50th percentile for height and weight, and presented at some st
age with borderline, hypochromic anaemia associated with red cell abno
rmalities and thrombocytopaenia. The oldest patient showed suggestive
clinical evidence of atherosclerosis affecting her aorta, ileofemoral
bifurcation and possibly coronary arteries. All homozygotes responded
to a diet restricted in phytosterols and the administration of cholest
yramine with falls in plasma sterols of up to 68%.The recent discovery
of a possible inherited defect in the synthesis of HMG CoA reductase
in patients with phytosterolaemia makes this disorder a model system f
or studying the biological role of this enzyme in regulating the absor
ption and clearance of sterols other than cholesterol, and the factors
governing the sterol composition of cell membranes.